Associated Papers
Broad Next-Generation Integrated Sequencing of Myelofibrosis Identifies Disease-Specific and Age-Related Genomic Alterations.
Kandarpa M et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2024
Clonal Evolution after Allogeneic Hematopoietic Stem Cell Transplantation: The Case of Myelofibrosis.
Christopeit M et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation, 2020
Progress in elucidation of molecular pathophysiology of myeloproliferative neoplasms and its application to therapeutic decisions.
Jia R et al.
International Journal of Hematology, 2020
Calreticulin Mutations in Bulgarian MPN Patients.
Pavlov I et al.
Pathology Oncology Research : Por, 2018
Isolated erythrocytosis associated with a CALR mutation.
Langabeer SE et al.
Blood Cells, Molecules & Diseases, 2017
Genetic Characteristics of Polycythemia Vera and Essential Thrombocythemia in Korean Patients.
Yoo EH et al.
Journal of Clinical Laboratory Analysis, 2016
Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.
Kang MG et al.
Oncotarget, 2016
Clinical Manifestation of Calreticulin Gene Mutations in Essential Thrombocythemia without Janus Kinase 2 and MPL Mutations: A Chinese Cohort Clinical Study.
Sun C et al.
Chinese Medical Journal, 2016
Low neutrophil alkaline phosphatase score is a new aspect of calreticulin-mutated myeloproliferative neoplasms.
Kondo T et al.
Springerplus, 2016
The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms.
Lin Y et al.
American Journal of Clinical Pathology, 2015
Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring.
Chi J et al.
Annals of Hematology, 2015
Incidence, clinical features, and prognostic impact of CALR exon 9 mutations in essential thrombocythemia and primary myelofibrosis: an experience of a single tertiary hospital in Korea.
Park SH et al.
Annals of Laboratory Medicine, 2015
Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients.
Qiao C et al.
Haematologica, 2014
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons.
Tefferi A et al.
Leukemia, 2014
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
Nangalia J et al.
The New England Journal of Medicine, 2013